Truveta company information, Employees & Contact Information

Monitoring Report: GLP-1 RA Prescribing Trends – June 2025 Data medRxiv

New administrative data in Truveta Data and features in GlobeNewswire

Leading US health systems launch the Truveta Genome Project, creating the world’s largest and most diverse database to discover the science of humanity Yahoo Finance

Truveta: EHR Data Company Raises $320 Million At Over $1 Billion Valuation Pulse 2.0

Truveta Data expands beyond EHR data with linked closed claims for more than 200 million patients GlobeNewswire

CFO of the Year 2025 The Business Journals

Truveta sells stakes to Regeneron, Illumina in deal to build genetic database Reuters

Regeneron To Invest $119.5 Mln In Truveta's Financing Round, Launch Truveta Genome Project Nasdaq

GLP-1 Receptor Agonists vs Alternatives for Alcohol Use Disorder: A Multi-Target Trial Emulation medRxiv

Racial inequality in COVID-treatment and in-hospital length of stay in the US over time Frontiers

Microsoft and Truveta announce strategic partnership to accelerate Truveta’s vision of saving lives with data Microsoft Source

Trends in Incidence of Syphilis Among US Adults from January 2017 to October 2024 American Journal of Preventive Medicine

Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study JACC Journals

New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications GlobeNewswire

Monitoring Report: Respiratory Viruses - October 2024 Data medRxiv

Truveta Data, the most complete, timely, and clean GlobeNewswire

Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research Yahoo Finance

Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data Yahoo Finance

First-Time Prescribing of GLP-1 Receptor Agonists from 2018-2023: A Descriptive Analysis medRxiv

Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers Yahoo Finance

How Truveta is using data and AI to improve patient care and save lives Microsoft Source

Monitoring Report: Respiratory Viruses - August 2024 Data medRxiv

Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study ScienceDirect.com

Seattle's newest unicorn: Truveta lands $320M to fuel creation of massive new genome project GeekWire

Introducing the Truveta Platform: Unprecedented GlobeNewswire

Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta’s Community to Accelerate Recruitment to Povetacicept Clinical Trials Yahoo Finance

Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems JACC Journals

Monitoring Report: Viral Gastroenteritis - August 2024 Data medRxiv

U.S. Health Giants Form Startup to Share, Analyze Patient Data Bloomberg.com

Monitoring Report: GLP-1 RA Prescribing Trends - September 2024 Data medRxiv

Monitoring Report: Respiratory Viruses - November 2024 Data medRxiv

Leading Health Providers Unite to Advance Patient Care by Forming Truveta PR Newswire

Truveta’s real-world data study comparing tirzepatide GlobeNewswire

Monitoring Report: Respiratory Viruses - March 2024 Data medRxiv

New study reveals shift in pediatric obesity treatment following AAP guidelines Yahoo Finance

Health systems-backed Truveta lands investment from Microsoft, cloud partnership Fierce Healthcare

Adalimumab Double Take: The Unexpected Return to Reference Humira Center for Biosimilars

Monitoring Report: GLP-1 RA Prescribing Trends - June 2024 Data medRxiv

Truveta's health data platform launches with $200M, insights on COVID breakthrough infections Fierce Healthcare

Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities medRxiv

Truveta Wants To Save Lives With Data But That’s A Tall Order Forbes

Opposing Reactions as RFK Jr. Removes Thimerosal from Flu Vaccines PharmTech

Truveta is making progress towards building a living medical portrait of America TechCrunch

Most adults with overweight or obesity discontinue GLP-1 therapy within 2 years Healio

Major Hospitals Form Company to Capitalize on Their Troves of Health Data - WSJ The Wall Street Journal

Tirzepatide led to greater real-world weight loss than semaglutide for adults with obesity Healio

GLP-1 Drugs: Food Industry Threat or Dieting Fad? The Food Institute